Biotech peptides investigate is reshaping how medicines are developed—shifting from wide-spectrum medications towards hugely distinct molecules that may be tuned for potency, selectivity, and client compatibility. In my look at, the most fun shift is not merely that peptides are “improved,” but that your entire discovery pipeline—synthesis,